The relevance of the intrinsic subtype to the clinicopathological features and biomarkers in Japanese breast cancer patients

Background Breast cancer is a disease rich in diversity, and it can be categorized into the immunohistochemical intrinsic subtypes : ER/PR + and HER2-, ER/PR + and HER2+, HER2 type, basal-like and unclassified.